Revolutionizing Healthcare with Electrogenetic Technology: Wearables Could Soon Control Gene Activity

A groundbreaking discovery by researchers from ETH Zürich in Switzerland promises a leap in personalized healthcare. Combining wearable technology with genetic engineering and electricity, this new development may revolutionize the way chronic diseases like diabetes are managed. The discovery introduces the concept of ‘electrogenic’ interfaces and opens a new frontier in medical science.

The Electrogenetic Breakthrough

What Is Electrogenetics?

Electrogenetics is a novel approach to controlling gene activity using electric currents. It operates by inducing changes in the cell’s DNA regulation with small pulses of electricity. While humans are born with a set of genes, the way these genes are activated or expressed can change as we age or modify our habits. Electrogenetics provides a way to control these changes, essentially turning specific genes “on” or “off.”

The DART Technology

The Swiss scientists have developed a technology called Direct Current (DC)-actuated Regulation Technology, or DART. Using small pulses of electricity, DART triggers insulin production in genetically engineered human pancreatic tissues.

Proof of Concept: Controlling Diabetes in Mice

Both human pancreatic cells and DART were implemented in mice with type 1 diabetes. The electric currents were applied through acupuncture needles to stimulate insulin production, and the results were remarkable:

  • The blood sugar levels of the diabetic mice returned to the normal range.
  • The electricity generated non-toxic levels of reactive oxygen species (ROS), triggering cellular activation.
  • The stimulation needed just 10 seconds once a day, and the effects were sufficient to manage glucose levels.
  • DART requires very little power, with three AA batteries enough to keep it running for five years.

Electrogenetic Interface and Its Potential

This discovery represents the first successful remote regulation of gene expression in a mammal using a DC-powered device. According to the study published in Nature Metabolism, this could be a “complete game changer” in healthcare. However, as Professor William Bentley of the University of Maryland noted, this is just the “tip of the iceberg” in terms of electronic control over biology.

From Fitbits to Metabolic Interventions

Current Role of Wearables

Wearable devices like Fitbits are already a part of daily life for many, tracking metrics like steps, heart rate, and blood pressure. However, their capabilities are currently limited to monitoring, not intervention.

Future Potential: Beyond Monitoring

The DART technology bridges this gap, paving the way for wearables to program metabolic interventions directly. The possibilities are staggering:

  • Wearable devices might be used to tune the activity of designer cells implanted in the human body, controlling gene expression.
  • Doctors could potentially intervene remotely from anywhere in the world, linking people’s metabolisms to an “internet of the body.”
  • Devices could be programmed to sense and adjust blood sugar automatically, eliminating the need for human intervention.

Challenges and the Road Ahead

Despite the promising proof of concept, there are challenges ahead. Integrating this technology into wearables like smartwatches might not be simple, and the idea of having engineered cells implanted might be unappealing to some.

Professor Martin Fussenegger, one of the lead researchers, conceded that there is still a long way to go. The next steps would include human clinical trials before the technology could be commercialized and integrated into wearable devices.


This groundbreaking research opens a new chapter in personalized medicine and healthcare technology. The ability to control gene expression through wearable devices offers unprecedented possibilities for medical intervention. While challenges remain, the future of electrogenetics holds immense promise, not only for the management of chronic conditions like diabetes but also for various genetic conditions. The world is indeed on the brink of a technological revolution that could change the way we approach health and well-being.